Effects of Bu Zhong Yi Qi decoction on CIH-induced interstitial lung fibrosis in mice

doi:10.12047/j.cjap.6316.2022.104

Abstract

Abstract: Objective: To investigate the effects of chronic intermittent hypoxia (CIH) on the expression of transforming growth factor-β (TGF-β), P-samd3, serum laminin (LN) and hyaluronidase (HA) in mouse lung tissues and the protective effects of Bu Zhong Yi Qi decoction on lung interstitial deposition damage in CIH mice. Methods: Fifty SPF-grade C57BL mice were randomly divided into five groups (n=10): blank control group, CIH model group, and CIH+ low, medium and high doses of Bu Zhong Yi Qi decoction group. Mice were placed under normoxia or CIH conditions, respectively. The Chinese medicine group was given the corresponding doses of drugs. HE staining was performed to assess pathological changes and Masson staining was performed to assess collagen deposition. Western blot was performed to detect the expressions of channel proteins such as TGF-β1, P-smad3 and down stream α-SMA and Collagen I. ELISA was performed to detect the serum levels of TGF-β1, LN and HA. Results: HE staining showed alveolar collapse, septal thickening and epithelial cell necrosis in CIH mice, Masson showed massive collagen fiber proliferation and deposition in lung interstitium, while the above changes in lung tissues were significantly improved in the CIH + Bu Zhong Yi Qi decoction groups compared with the CIH group. TGF-β1, P-smad3 and Collagen I, Collagen Ⅲ, and α-SMA expression levels were increased compared with the blank control group (P＜0.05), and the expressions of TGF-β1 and LN in serum were upregulated (P＜0.05). The expressions of TGF-β1, P-smad3, Collagen I protein and SMA-α in the lung tissues of the CIH+ Bu Zhong Yi Qi decoction groups were downregulated significantly compared with those of the CIH group (P＜0.05), and the improvement of multiple indexes in the CIH+high-dose CIH intervention group was better than those of the low-dose group (P＜0.05). Conclusion: Bu Zhong Yi Qi decoction can inhibit alveolar structural changes and excessive collagen deposition in the interstitium of CIH mice, and then improve lung function in CIH mice. The mechanism may be related to the down-regulation of protein expression related to TGF-β/smads signaling pathway by Bu Zhong Yi Qi decoction.

Key words: chronic intermittent hypoxia, Bu Zhong Yi Qi decoction, pulmonary fibrosis, TGF-β1, P-smad3, type I collagen, mice

CLC Number:

R542.2

TANG Yi, LIU Bing-bing, CHEN Qi, LI Ting-ting, JI En-sheng, LI Jie-ru. Effects of Bu Zhong Yi Qi decoction on CIH-induced interstitial lung fibrosis in mice[J]. CJAP, 2022, 38(5): 559-563.

References

[1] 纪赏, 陆学超. 阻塞性睡眠呼吸暂停综合征合并慢性阻塞性肺疾病的中西医研究进展[J]. 中文科技期刊数据库(引文版)医药卫生, 2019, 9(3): 293.
[2] Weng D, Chen JX, Li HH, et al. 2-aminopurine suppresses the Tgf-β1-induced epithelial-mesenchymal transition and attenuates bleomycin-induced pulmonary fibrosis[J]. Cell Death Discovery, 2018, 4(1): 17-27.
[3] Sgalla G, Iovene B, Calvello M, et al. Idiopathic pulmonary fibrosis: Pathogenesis and management[J]. Respir Res, 2018, 19(1): 32-50.
[4] 吕凌, 庞立健, 于漫, 等. 基于中医象思维的补中益气汤防治特发性肺纤维化研究[J]. 中华中医药学刊, 2020, 38(12): 252-255.
[5] 刘丽婷, 李杰, 吴童, 等. 从“治未病·既病防变——培土生金法”论《金匮要略·肺萎》篇中组方思路[J]. 天津中医药, 2019, 36(6): 572-574.
[6] 杨胜昌, 郭亚净, 于富洋, 等. 内皮素受体拮抗剂波生坦通过降低肾交感神经活性改善间歇性低氧大鼠的高血压[J]. 生理学报, 2018, 70(4): 354-360.
[7] 孟媛. 补中益气汤的临床应用进展[J]. 江西中医药, 2021, 52(11): 74-76.
[8] 陈志斌, 兰岚. 鼾症中医诊疗专家共识意见[J]. 中国中医药信息杂志, 2019, 26(1): 1-5.
[9] 管淑红, 王智刚, 朱煜明, 等. 柴胡皂甙D对肺纤维化小鼠上皮-间质转化的干预作用及机制研究[J]. 重庆医学, 2018, 47(22): 2913-2916.
[10] 栾智华, 柴智, 任晋宏, 等. 黄芪糖蛋白对博莱霉素诱导小鼠肺纤维化的干预作用及机制[J]. 中国老年学杂志, 2019, 39(6): 1411-1413.
[11] 罗文, 王涛, 熊国江, 等. 补中益气汤加减对非小细胞肺癌术后化疗患者VEGF,IGF-1,TGF-β1,免疫功能的影响及安全性分析[J]. 中国实验方剂学杂志, 2021, 27(16): 90-95.
[12] Varone F, Sgalla G, Iovene B, et al. Nintedanib for the treatment of idiopathic pulmonary fibrosis[J]. Expert Opin Pharmacother, 2018, 19(1/6): 167-175.
[13] 张旭, 魏华华, 谢敏, 等. 灯盏花素对低氧诱导的大鼠肺泡炎症及细胞外基质沉积的作用[J]. 西部医学, 2018, 30(8): 1099-1106.
[14] Kato S, Inui N, Hakamata A, et al. Changes in pulmonary endothelial cell properties during bleomycin-induced pulmonary fibrosis[J]. Resp Res, 2018, 19(1): 127-139.
[15] Jenkins RG, Simpson JK, Saini G, et al. Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre profile study[J]. Lancet Resp Med, 2015, 3(6): 462-471.
[16] 肖青雯, 陆金健, 陈修平. 靶向上皮间质转化:中药抗肿瘤转移和器官纤维化新策略[J]. 医药导报, 2018, 37(4): 401-409.
[17] 苏韫, 张毅, 李娟, 等. 红芪有效部位对肺间质纤维化模型大鼠肺组织胶原面积、透明质酸及层黏连蛋白的影响[J]. 中国中医药信息杂志, 2016, 23(4): 72-76.
[18] Morales-Nebreda LI, Rogel MR, Eisenberg JL, et al. Lung-specific loss of α3 laminin worsens bleomycin-induced pulmonary fibrosis[J]. Am J Resp Cell Mol Biol, 2015, 52(4): 503-512.
[19] Weng TT, Poth JM, Karmouty-Quintana H, et al. Hypoxia-induced deoxycytidine kinase contributes to epithelial proliferation in pulmonary fibrosis[J]. Am J Resp Crit Care Med, 2014, 190(12): 1402-1412.
[20] 吴礼循, 吴翔. 白介素11拮抗剂对实验性小鼠肺纤维化的作用[J]. 中国应用生理学杂志, 2021, 37(3): 308-312.
[21] 卢林明, 俞婷婷, 何晓伟, 等. 小剂量辣椒素抗小鼠肺纤维化的作用及其机制[J]. 中国应用生理学杂志, 2020, 36(3): 216-222.